Revenue recognition, reserve target exclusivity period Revenue Recognition Reserve Target Exclusivity Period Revenue recognition reserve target exclusivity period. Entity Address, City or Town Entity Address, City or Town Fair Value Disclosures [Abstract] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Research and Development, Net Research and Development Expense, Policy [Policy Text Block] FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Amendment Flag Amendment Flag Capital Expenditures Incurred but Not yet Paid Purchase of property and equipment in accounts payable and accrued expenses Contra expense included in research and development expense Contra Expense Included In Research And Development Expense Contra expense included in research and development expense. Share-based compensation number of shares authorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Vinbiocare [Member] Vinbiocare [Member] Vinbiocare. Subsequent Event Type [Domain] September 2021 Lease Agreement [Member] September Two Thousand And Twenty One Lease Agreement [Member] September two thousand and twenty one lease agreement. COVID-19 Vaccine Development C O V I D Nineteen Vaccine Development [Member] COVID-19 vaccine development. Operating lease right-of-use asset, net Operating Lease, Right-of-Use Asset Debt instrument, collateral Debt Instrument, Collateral Document Quarterly Report Document Quarterly Report Debt Instrument [Table] Schedule of Long-Term Debt Instruments [Table] Billing received amount from third party related to clinical trial Billing Received Amount Related to Clinical Trial Billing received amount related to clinical trial. Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Net Loss per Share Earnings Per Share, Policy [Policy Text Block] Equity-method investment Equity Method Investments Statement [Table] Statement [Table] Operating lease liability, net of current portion Operating Lease, Liability, Noncurrent Collaboration Partner Cure Vac Entered Into Co Development Agreement [Member] Collaboration Partner Cure Vac Entered Into Co Development Agreement [Member] Collaboration Partner Cure Vac entered into Co-Development Agreement. Number of operating segment for research and development Number of Operating Segments Royalty payment term description Royalty Payment Term Description Royalty payment term description. Common stock reserved for future issuance Common Stock, Capital Shares Reserved for Future Issuance Janssen [Member] Janssen [Member] Janssen. Commitment And Contingencies [Line Items] Commitment And Contingencies [Line Items] Commitment and contingencies. Product and Service Product and Service [Axis] Employee-related Liabilities, Current, Total Accrued compensation Employee-related Liabilities, Current Stock Option [Member] Share-Based Payment Arrangement, Option [Member] Upfront payment including taxes Upfront Payment Including Taxes Upfront payment including taxes. Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Total liabilities and stockholders’ equity Liabilities and Equity Tenant improvement allowance Payments for (Proceeds from) Tenant Allowance Plan Name Plan Name [Domain] Milestone payments Milestone Payments Milestone payments. Contractual term Collaboration Agreement Contractual Term Collaboration agreement contractual term. Upfront fee received Upfront Fee Received Upfront fee received. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Liquidity Liquidity Policy Policy [Text Block] Liquidity. Stock issued during period value under equity plan. Stock Issued During Period Value Under Equity Plan Issuance of common stock under equity plans Term loan draw down Borrowings under Guaranteed Investment Agreements Proceeds from the issuance of common stock under equity plans Proceeds from Stock Plans Potential principal repayment of loan Potential Principal Repayments Of Debt Instrument Potential Principal Repayments Of Debt Instrument. Sale of Stock Sale of Stock [Domain] Total current liabilities Liabilities, Current 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three Contract Assets, Additions for revenue recognized from billings Contract With Customer Asset Additions For Revenue Recognized Contract with customer asset additions for revenue recognized. Cystic Fibrosis Foundation [Member] Cystic Fibrosis Foundation Therapeutics Inc [Member] Cystic Fibrosis Foundation Therapeutics, Inc. Deferred revenue Increase (Decrease) in Contract with Customer, Liability Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Investment, Name Investment, Name [Domain] Entity Small Business Entity Small Business Cash and cash equivalents, including restricted cash Total cash, cash equivalents and restricted cash shown in the statement of cash flows Cash, cash equivalents and restricted cash at beginning of the period Cash, cash equivalents and restricted cash at end of the period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Payments for matching funds for remaining budgeted costs Payments For Matching Funds For Remaining Budgeted Costs Payments for matching funds for remaining budgeted costs. Total current assets Assets, Current Property Plant And Equipment [Line Items] Property, Plant and Equipment [Line Items] Summary of Changes in Balances of Contract Assets and Contract Liability Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] 2022 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted-average shares outstanding, basic February 2020 Lease Agreement [Member] February Two Thousand And Twenty Lease Agreement [Member] February two thousand and twenty lease agreement. Revenue. Revenue [Line Items] Revenue [Line Items] City Area Code City Area Code Share-Based Payment Arrangement [Abstract] Total liabilities Liabilities Private Placement [Member] Document Period End Date Document Period End Date Disbursement Due July 2020 [Member] Disbursement Period Three [Member] Disbursement period three. Lease Contractual Term Lease Contractual Term [Domain] Construction in progress [Member] Construction in Progress [Member] Research Collaboration And Exclusive License Agreement [Member] Research Collaboration And Exclusive License Agreement [Member] Research Collaboration and Exclusive License Agreement. Operating lease extended additional term Lessee, Operating Lease, Renewal Term Statistical Measurement Statistical Measurement [Axis] Lessee Operating Lease Liability Payments Due After Year Four Lessee operating lease liability payments due after year four. Thereafter Subsequent Event [Line Items] Related Party Related Party [Axis] Total assets Assets Contract with Customer, Asset, after Allowance for Credit Loss, Total Contract Assets, Balance Contract Assets, Balance Contract with Customer, Asset, after Allowance for Credit Loss Maximum LUNAR-COVID 19 sales required for Loans forgivable Maximum Sales Required For Loans Forgivable Maximum sales required for loans forgivable . Loan and Security Agreement [Member] Loan And Security Agreement [Member] Loan and security agreement. Long-term Debt, Excluding Current Maturities, Total Long-term debt, net of current portion Long-Term Debt, Excluding Current Maturities Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Net loss per share, diluted Dividends, Total Dividends declared or paid Dividends Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Fiscal Period Focus Document Fiscal Period Focus Prepayment fee percentage Prepayment Fee Percentage Prepayment fee percentage. Description of Business, Basis of Presentation and Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Adjustments to transaction price Adjustments To Transaction Price Adjustments to transaction price. Counterparty Name Counterparty Name [Domain] Operating Lease, Liability, Total Total operating lease liabilities Operating Lease, Liability Net cash used in (provided by) financing activities Net Cash Provided by (Used in) Financing Activities Contract Assets, Deductions for cash collections Contract With Customer Asset Deductions For Cash Collections Contract with customer asset deductions for cash collections. Statement of Financial Position [Abstract] Ultragenyx [Member] Ultragenyx [Member] Ultragenyx. Development and option agreement date Development And Option Agreement Date Development and option agreement date. Entity File Number Entity File Number Scenario Scenario [Domain] Statement of Cash Flows [Abstract] Balance Sheet Related Disclosures [Abstract] Exercise of warrants for shares of common stock Class of Warrant or Right, Number of Securities Called by Warrants or Rights Contra expense remaining amount included in accrued expenses Contra Expense Remaining Amount Included In Accrued Expenses Contra expense remaining amount included in accrued expenses. Proceeds from debt Net increase in indebtedness Proceeds from Issuance of Debt Geographical Geographical [Domain] Statistical Measurement Statistical Measurement [Domain] Statement of Stockholders' Equity [Abstract] Loan first principal payment extended maturity date Debt Instrument, Date of First Required Payment Sale of Stock Sale of Stock [Axis] Comprehensive loss: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Stockholders' Equity Note [Abstract] Equity method ownership percentage Equity Method Investment, Ownership Percentage Subsequent Events [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Investment in joint venture Equity Method Investment, Aggregate Cost ASC 606 [Member] Accounting Standards Update 2014-09 [Member] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Long-term Debt, Type Long-Term Debt, Type [Axis] Clinical accruals Clinical Accruals Current Clinical accruals current. October 2017 Lease Amendment [Member] October Two Thousand And Seventeen Lease Amendment [Member] October 2017 lease amendment. Summary of Components of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Revenue Revenue from Contract with Customer [Text Block] Preclinical milestone payment received. Preclinical Milestone Payment Received Preclinical milestone payment received Summary Of Significant Accounting Policy [Line Items] Summary Of Significant Accounting Policy [Line Items] Summary of significant accounting policy. Western Alliance Bank [Member] Western Alliance Bank [Member] Western Alliance Bank. Number of shares owned Investment Owned, Balance, Shares Disbursement Due April 2020 [Member] Disbursement Period Two [Member] Disbursement period two. Contingent grants member. Contingent Grants [Member] Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Cash consideration paid for equity interest in joint venture Payments to Acquire Interest in Joint Venture Subsequent Events Subsequent Events [Text Block] Weighted Average Number of Shares Outstanding, Diluted, Total Weighted Average Number of Shares Outstanding, Diluted Weighted-average shares outstanding, diluted COVID-19 Vaccine [Member] COVID-19 Vaccine [Member] COVID-19 vaccine. Current Short-Term Contract with Customer [Member] Other [Member] Other [Member] Other. Computer and software [Member] Computer Equipment [Member] General and Administrative [Member] General and Administrative Expense [Member] Current Fiscal Year End Date Current Fiscal Year End Date Revenue recognition potential milestone revenue recognized Revenue Recognition Potential Milestone Revenue Recognized Revenue recognition potential milestone revenue recognized. 2021 Inducement Equity Incentive Plan [Member] Twenty Twenty One Inducement Equity Incentive Plan [Member] 2021 Inducement equity incentive plan. Eligible to receive development milestone payment Eligible to Receive Development Milestone Payment Eligible to Receive Development Milestone Payment Grant revenue Grant revenue. Entity Address, Address Line One Entity Address, Address Line One Deferred Revenue, Noncurrent, Total Deferred revenue, net of current portion Deferred Revenue, Noncurrent Accrued Liabilities, Current [Abstract] Supplemental disclosure of cash flow information Supplemental Cash Flow Information [Abstract] Non-current restricted cash Non-current restricted cash Restricted Cash, Noncurrent Income Tax Expense (Benefit), Total Income tax expense Income Tax Expense (Benefit) Income Taxes Income Tax Disclosure [Text Block] Payments to Acquire Property, Plant, and Equipment, Total Acquisition of property and equipment Payments to Acquire Property, Plant, and Equipment Remaining performance obligation Revenue, Remaining Performance Obligation, Amount Income Tax Disclosure [Abstract] Number of reserved vaccine doses Number Of Reserved Vaccine Doses Number of reserved vaccine doses. Issuance of common stock Issuance of common stock, net of issuance costs (in shares) Stock Issued During Period, Shares, New Issues Pre-Launch Inventory Pre Launch Inventory Policy Policy [Text Block] Pre-launch inventory policy. Percentage of owned shares Investment Owned, Percent of Net Assets Upfront payment to be paid Upfront Payment Due Upfront payment due. Debt instrument, collateral amount Debt Instrument, Collateral Amount Revenue recognized Deductions for promised services provided in current period Contract with Customer, Liability, Revenue Recognized Upfront payment received Upfront Payment Received Upfront payment received. Loss from operations Operating Income (Loss) Lessee, operating leases, option to extend Lessee, Operating Lease, Option to Extend Related Party Related Party [Domain] Accrued interest added to principal debt balance Debt Instrument, Increase, Accrued Interest Scenario Scenario [Axis] Non-current Long-Term Contract with Customer [Member] Revenue. Revenue [Table] Revenue [Table] Acquired in-process research and development expense Non-cash charge recorded in acquired in-process research and development expense Research and Development in Process Entity Filer Category Entity Filer Category ADAIR Technology [Member] A D A I R Technology [Member] ADAIR Technology. February 2021 Lease Agreement [Member] February Two Thousand And Twenty One Lease Agreement [Member] February two thousand and twenty one lease agreement. Total operating expenses Operating Expenses Entity Current Reporting Status Entity Current Reporting Status Contra research and development expense recognized Contra Research And Development Expense Contra research and development expense. Research Collaboration And Exclusive License Agreement [Member] Research Collaboration And License Agreement [Member] Research collaboration and license agreement. Number of performance obligations Number Of Performance Obligations Number of performance obligations. Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Total stockholders’ equity Balance Balance Stockholders' Equity Attributable to Parent Statement of Cash Flows Inventory, Cash Flow Policy [Policy Text Block] Entity Tax Identification Number Entity Tax Identification Number Income Statement Location Income Statement Location [Axis] Common stock, $0.001 par value; 60,000 shares authorized; issued and outstanding shares were 26,492 at September 30, 2022 and 26,372 at December 31, 2021 Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Research equipment [Member] Equipment [Member] Common Stock [Member] Equity Components [Axis] Accounting Standards Update Accounting Standards Update [Domain] Amount agreed to fund Agreement Amount Agreed To Fund Agreement amount agreed to fund. Leases [Abstract] Contract with Customer, Liability, Total Deferred revenue Contract Liabilities, Balance Contract Liabilities, Balance Contract with Customer, Liability Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Entity Emerging Growth Company Entity Emerging Growth Company Operating expenses: Operating Expenses [Abstract] Grant 1 Grant One [Member] Grant one. Vinbiocare contractual liabilities Vinbiocare Contractual Liabilities Vinbiocare contractual liabilities. Revenue Recognition Revenue [Policy Text Block] CureVac [Member] Cure Vac A G [Member] CureVac AG. Schedule Of Stock By Class [Table] Schedule of Stock by Class [Table] Alexion [Member] Alexion Pharmaceuticals Inc [Member] Alexion Pharmaceuticals, Inc. Investment, Name Investment, Name [Axis] Payments for advance Payments for Advance to Affiliate Remaining available funding net of revenue earned Grant Revenue Outstanding Grant revenue outstanding. Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Document Transition Report Document Transition Report Upfront fee/consideration Upfront Fee And Consideration Upfront fee/consideration. Sale of Stock, Number of Shares Issued in Transaction Equity method investment, sale of common stock Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Vallon Pharmaceuticals, Inc. [Member] Vallon Pharmaceuticals Inc [Member] Vallon Pharmaceuticals, Inc. Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Net loss Net loss Net Income (Loss) Attributable to Parent Current portion of operating lease liability Operating Lease, Liability, Current Warrant fee payable Warrant Fee Payable Warrant fee payable. Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Monthly base rent Monthly Base Rent Monthly base rent. Development milestones Development milestones Development milestones. Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Entity Registrant Name Entity Registrant Name Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Loan maturity date Debt Instrument, Maturity Date Other accrued research and development expenses Other Accrued Research And Development Expenses Other accrued research and development expenses. Share-based Payment Arrangement, Noncash Expense, Total Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Grant Revenue [Abstract] Grant Revenue Abstract. Statement of Comprehensive Income [Abstract] Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Award Type Award Type [Domain] Statement [Line Items] Statement [Line Items] Title of 12(b) Security Title of 12(b) Security Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) in Accounts Payable Percentage required to be maintain in consolidated, unrestricted cash Percentage Required To Be Maintained In Consolidated Unrestricted Cash Percentage required to be maintained in consolidated unrestricted cash. Common Stock [Member] Common Stock [Member] OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Equity Component Equity Component [Domain] Revenue from Contract with Customer, Excluding Assessed Tax, Total Total revenue Revenue Revenue from Contract with Customer, Excluding Assessed Tax Schedule of Cash and Cash Equivalents and Restricted Cash Schedule of Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four Geographical Geographical [Axis] NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Document Type Document Type Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Disbursement Due October 2020 [Member] Disbursement Period Four [Member] Disbursement period four. Entity Shell Company Entity Shell Company Share-based compensation expenses Share-based compensation expenses Share-Based Payment Arrangement, Expense Interest Expense, Long-term Debt, Total Interest expense related to long-term debt Interest Expense, Long-Term Debt Grant awarded Grants Receivable Contract with Customer, Duration [Axis] Revenue, practical expedient description Revenue, Practical Expedient, Remaining Performance Obligation, Description Security Exchange Name Security Exchange Name Revenue from Contract with Customer [Abstract] Class Of Stock [Line Items] Class of Stock [Line Items] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Grant Revenue Grant Revenue Disclosure [Text Block] The entire disclosure for grant revenue. Loan accrues interest rate per annum, percentage Debt Instrument, Interest Rate, Effective Percentage Commitments and Contingencies Disclosure [Abstract] Operating lease costs Operating Lease, Cost Remaining Payments of Operating Lease Liability Lessee, Operating Lease, Liability, Maturity [Table Text Block] New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Standards Not Yet Adopted Percentage of equity interest in joint venture Percentage Of Equity Interest In Joint Venture Percentage of equity interest in joint venture. Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Debt Debt Disclosure [Text Block] Proceeds from Issuance of Long-term Debt, Total Proceeds from long-term debt agreement Proceeds from Issuance of Long-Term Debt Deferred Revenue, Current, Total Deferred revenue Deferred Revenue, Current INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Net profits percentage Percentage Of Net Profits Percentage of net profits. Vinbiocare Agreement [Member] Vinbiocare Agreement [Member] Vinbiocare agreement. Common stock, shares issued Issuance of Shares Common Stock, Shares, Issued, Total Purchase of common stock, shares Minimum [Member] Minimum [Member] LUNAR-CF [Member] L U N A R C F [Member] LUNAR-CF. Common stock issued, value Stock Issued During Period, Value, Issued for Services Leases Lessee, Leases [Policy Text Block] Accounting Standards Update Accounting Standards Update [Axis] Notice period of termination Notice Period Of Termination Notice period of termination. Total Accrued liabilities Accrued Liabilities, Current Stockholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Gain from foreign currency Foreign currency transaction gain Foreign Currency Transaction Gain (Loss), before Tax, Total Foreign Currency Transaction Gain (Loss), before Tax Counterparty Name Counterparty Name [Axis] Entity Address, Address Line Two Entity Address, Address Line Two Reduction in number of common stock shares available for future issuance Reduction in Number of Common Stock Capital Shares Available for Future Issuance Reduction in number of common stock capital shares available for future issuance. Award Type Award Type [Axis] Other Noncash Income (Expense), Total Other non-cash expenses Other Noncash Income (Expense) Subsequent Event Subsequent Event [Member] Other Nonoperating Income (Expense), Total Finance expense, net Other Nonoperating Income (Expense) Long-term Debt, Current Maturities, Total Current portion of long-term debt Long-Term Debt, Current Maturities Research and Development Expense, Total Research and development, net Research and Development Expense Total remaining lease payments Lessee, Operating Lease, Liability, to be Paid 2019 Omnibus Equity Incentive Plan [Member] Two Thousand Nineteen Omnibus Incentive Plan [Member] Two thousand nineteen omnibus incentive plan. Lessee, operating lease, term of contract Lessee, Operating Lease, Term of Contract Pharmaceutical Company [Member] Pharmaceutical Company [Member] Pharmaceutical company. Entity Central Index Key Entity Central Index Key Eligible to receive commercial milestone payment Eligible to Receive Commercial Milestone Payment Eligible to receive commercial milestone payment. Israel ministry of health. Israel Ministry of Health [Member] Israel Ministry of Health [Member] Accounting Policies [Abstract] Total quarterly payments payable on terminations agreement Quarterly Payments Payable On Terminations Agreement Quarterly payments payable on terminations agreement. Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment [Table] Quarterly payments payable Additional Payment Payable on Quarterly Additional payment payable on quarterly. Number of shares available Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Share-Based Compensation Expense Share-Based Payment Arrangement [Text Block] Subsequent Event [Table] General and Administrative Expense, Total General and administrative General and Administrative Expense Study Support Agreement Study Support Agreement [Member] Study support agreement. Research and Development [Member] Research and Development Expense [Member] Right-of-use assets acquired through operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Equity Method Investment, Nonconsolidated Investee Equity Method Investment, Nonconsolidated Investee [Domain] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Accumulated Deficit [Member] Retained Earnings [Member] Security deposit Security Deposit Loss (gain) from equity-method investment Income (Loss) from Equity Method Investments, Total Income (Loss) from Equity Method Investments Gain (loss) from equity-method investment Upfront payment to be received Upfront Payment to be Received Upfront payment to be received. Operating Lease Liability Current Statement Of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property and equipment, gross Property, Plant and Equipment, Gross Contract with Customer, Duration [Domain] Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Additional paid-in capital Additional Paid in Capital Entity Interactive Data Current Entity Interactive Data Current Related Party Transactions Related Party Transactions Disclosure [Text Block] Received first installment Payment Received First Installment Payment received first installment. Non-cash investing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Related Party Transactions [Abstract] Lessee Operating Lease Liability Payments Due Next Twelve Months, Total 2023 Lessee, Operating Lease, Liability, to be Paid, Year One Leasehold improvements [Member] Leasehold Improvements [Member] Local Phone Number Local Phone Number Final payment of disbursement amount Final Payment Of Disbursement Amount Final payment of disbursement amount. Long-term Debt [Member] Long-Term Debt [Member] Debt Disclosure [Abstract] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Lease Contractual Term Lease Contractual Term [Axis] Commitment And Contingencies [Table] Commitment And Contingencies [Table] Commitment and contingencies. Schedule of Revenue Disaggregation of Revenue [Table Text Block] Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums, Total Loan origination fee paid Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums Other non-current liabilities Other Liabilities, Noncurrent Income Statement Location Income Statement Location [Domain] 2023 Long-Term Debt, Maturity, Year One Non-refundable payment received Non Refundable Payment Received Non-refundable payment received. mRNA Technology [Member] M R N A Technology [Member] mRNA technology. Property, Plant and Equipment [Abstract] Total Long-term debt Long-Term Debt Balance (in shares) Balance (in shares) Shares, Outstanding Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expense and other assets Increase (Decrease) in Prepaid Expense and Other Assets Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Document Fiscal Year Focus Document Fiscal Year Focus Payments on debt obligations Repayments of Debt 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per share, basic Schedule Of Summary Of Significant Accounting Policies [Table] Schedule Of Summary Of Significant Accounting Policies [Table] Schedule of summary of significant accounting policies. Assets Assets [Abstract] Increase (Decrease) in Accrued Liabilities, Total Accrued liabilities Increase (Decrease) in Accrued Liabilities Arcalis, Inc [Member] Arcalis, Inc. Prepaid expenses and other current assets Prepaid Expenses And Other Receivables The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. as well as trade accounts receivable, notes and loans receivable. Agreement termination costs Agreement Termination Fee Agreement Termination Fee. Term loan Debt Instrument, Face Amount Long-Lived Tangible Asset Long-Lived Tangible Asset [Axis] Singapore Economic Development Board [Member] SINGAPORE Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Royalty payment percentage of proceeds from net sales Royalty Payment Percentage Royalty payment percentage. Current assets: Assets, Current [Abstract] Share price Class of Warrant or Right, Exercise Price of Warrants or Rights Disbursed amount upon execution of amendment Disbursed Amount Upon Execution Of Amendment Disbursed amount upon execution of amendment. Underlying Agreement [Member] Underlying Agreement [Member] Underlying agreement. Loan interest-only payment extended maturity date Debt Instrument Interest Only Payment Extended Maturity Date Debt instrument interest only payment extended maturity date. Joint Ventures, Equity Method Investments and Variable Interest Entities Joint Ventures Equity Method Investments And Variable Interest Entities Policy [Text Block] Joint ventures, equity method investments and variable interest entities. Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Stock issued during period shares under equity plan. Stock Issued During Period Shares Under Equity Plan Issuance of common stock under equity plans (in shares) Related Party Transaction [Line Items] Related Party Transaction [Line Items] Additional payment Additional Upfront Payment Additional upfront payment. Maximum potential upfront payment amount payable Maximum Potential Upfront Payment Amount Payable On Termination Of Agreement Maximum potential upfront payment amount payable on termination of agreement. Cover [Abstract] Product and Service Product and Service [Domain] Foreign currency transaction gain Foreign Currency Transaction Gain (Loss), Realized Current liabilities: Liabilities, Current [Abstract] Maximum [Member] Maximum [Member] Royalty payments Royalty Payments Royalty payments. Disbursement payment upon achievement of required manufacturing practices and IND application Disbursement Payment Upon Achievement Of Required Manufacturing Practices And I N D Application Disbursement payment upon achievement of required manufacturing practices and IND application. Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Office equipment and furniture [Member] Furniture and Fixtures [Member] Issuance of common stock upon exercise of stock options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Value added tax payable Value Added Tax Payable Value added tax payable. Schedule of Share-based Compensation Expenses Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Interest of the prime rate plus Debt Instrument, Basis Spread on Variable Rate 2022 Long-Term Debt, Maturity, Remainder of Fiscal Year Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Segment Information Segment Reporting, Policy [Policy Text Block] Seqirus, Inc [Member] Seqirus, Inc [Member] Seqirus, Inc. Contract Liabilities, Additions for advanced billings Contract With Customer Liability Additions For Advanced Billings Contract With Customer Liability Additions For Advanced Billings Contract Liabilities, Reclassifications to accrued liabilities Contract With Customer, Liability, Reclassifications To Accrued Liabilities Contract with customer, liability, reclassifications to accrued liabilities. Common stock, shares authorized Common Stock, Shares Authorized Trading Symbol Trading Symbol Acquisition of in-process research and development through issuance of common stock Acquisition Of Research And Development In Process Through Issuance Of Common Stock Acquisition of research and development in process through issuance of common stock. Grant, number of installments Grant Receivable Number Of Installments Grant receivable number of installments. Disbursement Due January 2020 [Member] Disbursement Period One [Member] Disbursement period one. commercial milestones Commercial Milestones Commercial milestones. Percentage of value added tax Percentage Of Value Added Tax Percentage of value added tax. Disbursement amount payable upon achievement of project goal Disbursement Amount Payable Upon Achievement Of Project Goal Disbursement amount payable upon achievement of project goal. Subsequent Event Type [Axis] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Grant 2 Grant Two [Member] Grant two. Accrued liabilities paid upon occurrence of specified events Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized Extension to interest only period Debt Instrument Interest Only Payment Extended Period Debt instrument interest only payment extended period. Plan Name Plan Name [Axis] Schedule Of Related Party Transactions By Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Upfront payment payable Upfront Payment Payable Upfront payment payable. Long-Lived Tangible Asset Long-Lived Tangible Asset [Domain] Cystic Fibrosis Foundation Liability (Note 9) Accrued Cystic Fibrosis Foundation Liability Accrued cystic fibrosis foundation liability. Axcelead, Inc [Member] Axcelead Inc [Member] Axcelead, Inc. Equity Method Investment, Nonconsolidated Investee Equity Method Investment, Nonconsolidated Investee [Axis] Common stock, par value Common Stock, Par or Stated Value Per Share Issuance of common stock related to acquired in-process research and development (in shares) Stock Issued During Period, Shares, Acquisitions Other Collaboration Agreements [Member] Other Collaboration Agreements [Member] Other collaboration agreements. Issuance of common stock related to acquired in-process research and development Stock Issued During Period, Value, Acquisitions Debt Instrument [Line Items] Debt Instrument [Line Items] Long-term Debt, Type Long-Term Debt, Type [Domain] Antidilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Israeli Ministry of Health ("MOH") [Member] ISRAEL